English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [5427]
News [12613]
Articles [172]
Editorials [5]
Conferences [246]
elearning [17]
Monitoring patterns of care in mCRPC patients with the help of the Cancer...
Dr Simon Chowdhury - Guy's Hospital, London, UK
Monitoring patterns of care in mCRPC patients with the help of the Cancer Registry ( Dr Simon Chowdhury - Guy's Hospital, London, UK )
10 Oct 2016
Lurbinectedin in BRCA 1/2 breast cancer
Dr Judith Balmaña - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Lurbinectedin in BRCA 1/2 breast cancer ( Dr Judith Balmaña - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016
Olaparib and paclitaxel for 2nd line gastric cancer therapy
Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea
Olaparib and paclitaxel for 2nd line gastric cancer therapy ( Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea )
10 Oct 2016
Innovative uses of kinase inhibitors in cancer
Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Innovative uses of kinase inhibitors in cancer ( Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016
Comment: Ipilimumab in high risk stage III melanoma
Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium
Comment: Ipilimumab in high risk stage III melanoma ( Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium )
10 Oct 2016
Comment: Niraparib for ovarian cancer
Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium
Comment: Niraparib for ovarian cancer ( Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium )
10 Oct 2016
Comment: Ribociclib for breast cancer
Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium
Comment: Ribociclib for breast cancer ( Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium )
10 Oct 2016
Treating CNS metastases from breast cancer with a peptide/paclitaxel conjugate
Prof Shou-Ching Tang - Augusta University Cancer Center, Augusta USA
Treating CNS metastases from breast cancer with a peptide/paclitaxel conjugate ( Prof Shou-Ching Tang - Augusta University Cancer Center, Augusta USA )
10 Oct 2016
Highlights of ESMO 2016
Dr Andrés Cervantes - ESMO 2016 Scientific Chair
Highlights of ESMO 2016 ( Dr Andrés Cervantes - ESMO 2016 Scientific Chair )
10 Oct 2016
Adjuvant sunitinib for renal cell carcinoma
Dr Alain Ravaud - Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
Adjuvant sunitinib for renal cell carcinoma ( Dr Alain Ravaud - Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France )
10 Oct 2016
Longer disease-free survival in phase III trial of sunitinib as adjuvant...
Dr Alain Ravaud - Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer ( Dr Alain Ravaud - Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France )
10 Oct 2016
What is the future of proton therapy in the UK and worldwide?
Mr John Pettingell - Proton Partners International, Cardiff, UK
What is the future of proton therapy in the UK and worldwide? ( Mr John Pettingell - Proton Partners International, Cardiff, UK )
10 Oct 2016
<1...303304305306307...453>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top